Article Citations

(Scroll Down for More)

Clinical phase II/III trial of Ustekinumab to treat type 1 diabetes.

Principal Investigator

Locations

BC Diabetes | Vancouver,British Columbia

Mount Sinai Hospital | Toronto,Ontario

Study Code

ITN832AI

Study Status

Follow-up

Abstract

Qualification

Articles